[1] 付喜花, 张振华, 刘婉婷,等. 核苷酸类药物治疗乙型肝炎病毒感染导致的慢加急性肝衰竭患者疗效分析. 实用肝脏病杂志, 2017, 20:69-72.
[2] 庞国宏, 杨汝磊. 中西医辨证治疗乙型肝炎病毒慢加急性肝衰竭. 吉林中医药, 2017, 37:363-366.
[3] Lin BL, Chen JF, Qiu WH, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial.Hepatology, 2017, 66:209-219.
[4] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 中华肝脏病杂志, 2013, 21:177-183.
[5] Tan W, Xia J, Dan Y, et al. Genome-wide association study identifies HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure. Gut, 2018,67:757-766.
[6] Signorelli SS, Volsi GL, Pitruzzella A, et al. Circulating miR-130a, miR-27b, and miR-210 in patients with peripheral artery disease and their potential relationship with oxidative stress. Angiology, 2016, 67:945-950.
[7] Ramalho-Carvalho J, Martins JB, Cekaite L, et al. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Cancer Lett, 2017, 385:150-159.
[8] Han B, Lian L, Li X, et al. Chicken gga-miR-130a targets HOXA3 and MDFIC and inhibits Marek's disease lymphoma cell proliferation and migration. Mol Biol Rep, 2016, 43:667-676.
[9] Choi GH, Ko KH, Kim JO, et al. Association of miR-34a, miR-130a, miR-150 and miR-155 polymorphisms with the risk of ischemic stroke. Int J Mol Med, 2016, 38:345-356. |
